NASDAQ · MEOH
Methanex Corporation
$62.76-$0.79 (-1.24%)
Methanex Corporation’s quoted price sits in the upper half of its reported 52-week range, 5.98% below the high.
Loading market information…
NYSE · ASH · USD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Ashland Inc.’s quoted price sits in the upper half of its reported 52-week range, 4.95% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Ashland Inc.’s forward annual dividend is $1.68 per share, paid quarterly. The forward yield is 2.26% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Ashland Inc.’s next earnings report is currently expected on Nov 3, 2026, with estimated earnings per share of $1.27. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Ashland Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Ashland Inc. operates as a global supplier of specialized chemicals and additives. Its business activities are structured into four main divisions: Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents. The Life Sciences segment delivers pharmaceutical formulations, encompassing controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and binding agents for tablets. It also offers nutritional compounds like thickeners, stabilizers, emulsifiers, and various additives, alongside nutraceutical items designed for weight management, joint comfort, gastrointestinal health, sports nutrition, and general well-being. Additionally, this division provides custom formulation services, toll processing, and particle engineering expertise. The Personal Care & Household division manufactures a diverse array of naturally derived, biodegradable, and high-performance ingredients for personal care products. Its offerings extend to solutions for oral hygiene, such as toothpastes, mouthwashes, denture cleansers, and general dental care. For household applications, it supplies nature-sourced rheology modifiers, biodegradable wetting agents for surfaces, advanced encapsulants, and specialized polymers. The Specialty Additives segment's portfolio includes rheology modifiers, agents for foam control, surfactants, wetting agents, pH neutralizers, and advanced ceramic materials, which find application in catalytic converters, environmental filters, components for ceramic capacitors, plasma display panels, and solar cells. Furthermore, it supplies ingredients for textile printing, thermoplastic metals, and alloys utilized in welding processes. The Intermediates and Solvents division is responsible for producing 1,4 butanediol and its associated derivatives, notably n-methylpyrrolidone. Ashland's diverse product portfolio serves clientele across numerous consumer and industrial sectors, including architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceuticals. The company, previously known as Ashland Global Holdings Inc., was established in Wilmington, Delaware, in 1924.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:52 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q2 2025 |
|---|
| Apr 30, 2025 |
| $0.99-10.0% vs estimate |
| $479.00M-4.7% vs estimate |
| Q1 2025 | Jan 28, 2025 | $0.28+40.0% vs estimate | $405.00M-5.61% vs estimate |
|---|
| Q4 2024 | Nov 7, 2024 | $1.26-1.56% vs estimate | $522.00M-0.39% vs estimate |
|---|
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
THE ANALYST VIEW
25 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 8 contributors · Median target $77.50.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$62.76-$0.79 (-1.24%)
Methanex Corporation’s quoted price sits in the upper half of its reported 52-week range, 5.98% below the high.
$42.88+$0.69 (+1.64%)
Avient Corporation’s quoted price sits in the upper half of its reported 52-week range, 8.06% below the high.
$28.31-$1.34 (-4.52%)
Skeena Resources Limited’s quoted price sits in the upper half of its reported 52-week range, 26.98% below the high.
$219.41+$5.33 (+2.49%)
WD-40 Company’s quoted price sits in the lower half of its reported 52-week range, 26.59% below the high.
$157.87+$0.95 (+0.61%)
Quaker Houghton’s quoted price sits in the upper half of its reported 52-week range, 13.74% below the high.
$75.37+$1.20 (+1.62%)
Ingevity Corporation’s quoted price sits in the upper half of its reported 52-week range, 4.94% below the high.
$101.41+$0.71 (+0.71%)
Innospec Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.38% below the high.
$13.19-$0.17 (-1.27%)
The Chemours Company’s quoted price sits in the lower half of its reported 52-week range, 53.99% below the high.
